Aquestive Therapeutics, Inc. AQST Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s other accrued liabilities?
- Aquestive Therapeutics, Inc. (AQST) reported other accrued liabilities of $53K in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s other accrued liabilities changed year-over-year?
- Aquestive Therapeutics, Inc.'s other accrued liabilities decreased by 35.4% year-over-year, from $82K to $53K.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s other accrued liabilities?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s other accrued liabilities has grown at a -37.3% compound annual growth rate (CAGR), from $517K to $50K.